FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称CLENOLIXIMAB
异名/同义词CE9.GAMMA.4PE
CLENOLIXIMAB
CLENOLIXIMAB [INN]
CLENOLIXIMAB [WHO-DD]
IDEC151
IDEC-151
IMMUNOGLOBULIN G 4 (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN ANTI-HUMAN ANTIGEN CD 4), DISULFIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G 4 (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN ANTI-HUMAN ANTIGEN CD 4), DISULPHIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4, ANTI-(HUMAN CD4 (ANTIGEN)) (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .LAMBDA.-CHAIN, DIMER
CAS登记号182912-58-9
物质唯一标识(Unique Ingredient Identifier)78EVW7GX37
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System